Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Cardiomyopathy, Dilated

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Cardiomyopathy, Dilated in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ribas, FF1
Gutierrez, PS1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Cardiomyopathy, Dilated

ArticleYear
Case 6 / 2016 - Heart Failure in a 23-Year-Old Male with a History of Illicit Drug Use.
    Arquivos brasileiros de cardiologia, 2016, Volume: 107, Issue:6

    Topics: Cardiomyopathy, Dilated; Cocaine-Related Disorders; Crack Cocaine; Echocardiography; Fatal Outcome;

2016